Safety of midazolam for sedation of HIV‐positive patients undergoing colonoscopy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  HIV Medicine

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/hiv.12014PMID 23332038PMCID PMC4120820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How Providers Treat HIV: An Analysis of Provider Opinion and Adoption of the 2012 DHHS Guidelines for the use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents

  2013cited by this paper
• Severe Prolonged Sedation Associated with Coadministration of Protease Inhibitors and Intravenous Midazolam During Bronchoscopy

  2012cited by this paper
• Endoscopic sedation of patients with chronic liver disease.

  2010cited by this paper
• Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam

  2009cited by this paper
• Sedation and anesthesia in GI endoscopy.

  2008cited by this paper
• Sedation and anesthesia in GI endoscopy.

  2008cited by this paper
• CD4+ Count–Guided Interruption of Antiretroviral Treatment

  2007cited by this paper
• Sedation for gastrointestinal endoscopy: the changing landscape

  2007cited by this paper
• Anesthesia and sedation outside the operating room: how to prevent risk and maintain good quality

  2007cited by this paper
• EVALUATING THE SAFETY OF MIDAZOLAM FOR PROCEDURAL SEDATION IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS ON PROTEASE INHIBITORS

  2007cited by this paper
• Endoscopic Sedation in the United States: Results from a Nationwide Survey

  2006cited by this paper
• CD4+ count-guided interruption of antiretroviral treatment.

  2006cited by this paper
• Pharmacokinetic and Pharmacodynamic Characteristics of Medications Used for Moderate Sedation

  2006cited by this paper
• Sedative Drug Requirements during Flexible Bronchoscopy

  2005cited by this paper
• HIV and anesthesia.

  2004cited by this paper
• Drug Interactions Between Antiretroviral Drugs and Comedicated Agents

  2003cited by this paper
• Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy.

  2003cited by this paper
• Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition

  2000cited by this paper
• The Effect of Ritonavir on the Pharmacokinetics of Meperidine and Normeperidine

  2000cited by this paper
• A comparison of midazolam and diazepam for conscious sedation during colonoscopy in a prospective double-blind study.

  1999cited by this paper
• Pharmacokinetic and Pharmacodynamic Consequences of Metabolism‐Based Drug Interactions with Alprazolam, Midazolam, and Triazolam

  1999cited by this paper
• Ritonavir's role in reducing fentanyl clearance and prolonging its half-life.

  1999cited by this paper
• Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam

  1999cited by this paper
• Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.

  1997cited by this paper
• Midazolam: a review of therapeutic uses and toxicity.

  1997cited by this paper
• The Effect of the Systemic Antimycotics, Itraconazole and Fluconazole, on the Pharmacokinetics and Pharmacodynamics of Intravenous and Oral Midazolam

  1996cited by this paper
• Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

  1995cited by this paper
• Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers

  1995cited by this paper
• Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.

  1994cited by this paper
• A potentially hazardous interaction between erythromycin and midazolam.

  1993cited by this paper

• Safety of remimazolam in comparison with midazolam for colonoscopy: A systematic review and meta-analysis

  2024cites this paper
• Ritonavir May Prolong Sedation but is Unlikely to Increase the Risk of Respiratory Arrest in Patients Requiring Intravenous Midazolam for Procedural Sedation

  2024cites this paper
• Clinically important drug–drug interactions in patients admitted to hospital with COVID-19: drug pairs, risk factors, and management

  2020cites this paper